You are here

obesity

Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy

Fierce Pharma

Fri, 01/17/25 - 11:34 am

clinical trials

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance

Clinical Trials Arena

Tue, 01/14/25 - 09:54 am

Pfizer going 'all in' on obesity drug development, CEO Bourla says

Investing.com

Mon, 01/13/25 - 05:37 pm

2024 was a record year for obesity trials and 2025 is already poised to take over

Clinical Trials Arena

Mon, 01/13/25 - 11:07 am

clinical trials

Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial

Fierce Biotech

Mon, 01/13/25 - 11:01 am

Kailera Therapuetics

clinical trials

Jiangsu Hengrui Pharmaceuticals

5 questions facing pharma in 2025

BioPharma Dive

Fri, 01/10/25 - 11:47 am

Verdiva Bio raises $411m for obesity pipeline

Pharmaphorum

Thu, 01/9/25 - 11:06 am

Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes

Fierce Biotech

Wed, 01/8/25 - 11:23 am

artificial intelligence

3 trial readouts that could shake up the obesity market this year

Pharma Voice

Wed, 01/8/25 - 11:15 am

Skye Bioscience

clinical trials

FDA sets bar for obesity drug development as pipeline swells

First Word Pharma

Tue, 01/7/25 - 06:52 pm

Use of diabetes and anti-obesity drugs surges nationwide

Axios

Fri, 01/3/25 - 10:07 am

Merck joins obesity pill race with up to $2B Hansoh deal

BioSpace

Wed, 12/18/24 - 11:18 am

A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss

Pharmaphorum

Wed, 12/18/24 - 11:14 am

UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy

Yahoo/Reuters

Fri, 12/13/24 - 11:43 am

BioAge shares tumble after decision to halt obesity drug study

BioPharma Dive

Sun, 12/8/24 - 09:46 pm

clinical trials

Antag, a startup backed by Versant and Novo, joins hunt for obesity drug alternatives

BioPharma Dive

Wed, 12/4/24 - 11:15 pm

Antag Therapeutics

For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access

Fierce Pharma

Wed, 12/4/24 - 11:05 pm

Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial

BioPharma Dive

Wed, 12/4/24 - 11:02 am

clinical trials

Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment

Clinical Trials Arena

Wed, 12/4/24 - 10:54 am

Arrowhead Pharmaceuticals

clinical trials

Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

MSN

Wed, 11/27/24 - 09:57 pm

Pages